During the 2024 Society of Toxicology (SOT) Conference in Salt Lake City, Ken Kearney (Charles River Laboratories) shared the results of a study, evaluating the ability of our jacketed external telemetry system to capture ECG and respiratory data simultaneously, from ECG leads.
He also explored the process of correcting a poor calibration through retrospective analysis, all while upholding GLP compliance with clear audit trails.
Dr. Ken Kearney obtained his Bachelor of Science in Biology from Ashland University in 2005.
In 2006, he began his career as a biologist at WIL Research in Ashland, OH. During his tenure within the cardiovascular pharmacology group, he has held roles of data analyst and project leader where he was responsible for qualitative and quantitative measurement of physiological signals. In 2010, he moved to the Study Director position.
Today, Dr. Kearney is the Director of Pharmacology and Discovery Services at Charles River Laboratories ASH (formerly WIL Research). He actively contributes to the Safety Pharmacology Society as a valued member and holds honors of Diplomat of Safety Pharmacology. He is currently involved in the SPS ECG and EEG certificate course planning groups.
With 40 published abstracts and 14 professional presentations, Dr. Kearney makes significant contributions to the scientific community.
By browsing this website, you accept the use of cookies for statistical purposes.
When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.
